Media Summary: Killing Cancer Cells Biography: Wafik El-Deiry, This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve ... The Lymphoma Program is part of the Hematologic Oncology Treatment Center. Our specialists are experienced in providing ...

Michael B Dabrow Do Facp - Detailed Analysis & Overview

Killing Cancer Cells Biography: Wafik El-Deiry, This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve ... The Lymphoma Program is part of the Hematologic Oncology Treatment Center. Our specialists are experienced in providing ... Is there a cure for WM? Dr. Steve Treon, Director of the Bing Center for WM Research, makes the case that with so many ... TO RECEIVE CONTINUING MEDICAL EDUCATION (CME) CREDIT CLICK LINK BELOW Access to CMEs for this activity expires ... In this week's , myeloma expert Dr. Brian G.M. Durie answers the question: What

Photo Gallery

Michael B. Dabrow, DO, FACP, FACOI | Hematology/Oncology
Michael Daunov, DO - Hematology & Oncology
By Faculty for Faculty: Professor Wafik El-Deiry, MD, PhD, FACP
Michael Brown, PhD
Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Current and em...
Michael E. Pacold, MD, PhD, a Damon Runyon Scientist
Jason Damsker, MD, FACP | Medical Oncologist
Eric Jacobsen, MD, Clinical Director | DFCI Adult Lymphoma Program
2025 Nov Ed Forum Dr. Steve Treon; "Progress towards a Cure"
Meet Brennen O'Dell, DPM, DABPM, AACFAS
Recent advancements in BPDCN: diagnostic criteria, pathophysiology, and treatment
VITALS with Kirsten Frederiksen, M.D., M.S., FACP, FOMA, DABOM (CME credit available)
View Detailed Profile
Michael B. Dabrow, DO, FACP, FACOI | Hematology/Oncology

Michael B. Dabrow, DO, FACP, FACOI | Hematology/Oncology

Meet

Michael Daunov, DO - Hematology & Oncology

Michael Daunov, DO - Hematology & Oncology

Michael

By Faculty for Faculty: Professor Wafik El-Deiry, MD, PhD, FACP

By Faculty for Faculty: Professor Wafik El-Deiry, MD, PhD, FACP

Killing Cancer Cells Biography: Wafik El-Deiry,

Michael Brown, PhD

Michael Brown, PhD

Michael

Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Current and em...

Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Current and em...

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve ...

Michael E. Pacold, MD, PhD, a Damon Runyon Scientist

Michael E. Pacold, MD, PhD, a Damon Runyon Scientist

Michael

Jason Damsker, MD, FACP | Medical Oncologist

Jason Damsker, MD, FACP | Medical Oncologist

Jason Damsker,

Eric Jacobsen, MD, Clinical Director | DFCI Adult Lymphoma Program

Eric Jacobsen, MD, Clinical Director | DFCI Adult Lymphoma Program

The Lymphoma Program is part of the Hematologic Oncology Treatment Center. Our specialists are experienced in providing ...

2025 Nov Ed Forum Dr. Steve Treon; "Progress towards a Cure"

2025 Nov Ed Forum Dr. Steve Treon; "Progress towards a Cure"

Is there a cure for WM? Dr. Steve Treon, Director of the Bing Center for WM Research, makes the case that with so many ...

Meet Brennen O'Dell, DPM, DABPM, AACFAS

Meet Brennen O'Dell, DPM, DABPM, AACFAS

Meet Brennen O'Dell, DPM, DABPM, AACFAS

Recent advancements in BPDCN: diagnostic criteria, pathophysiology, and treatment

Recent advancements in BPDCN: diagnostic criteria, pathophysiology, and treatment

Andrew Lane,

VITALS with Kirsten Frederiksen, M.D., M.S., FACP, FOMA, DABOM (CME credit available)

VITALS with Kirsten Frederiksen, M.D., M.S., FACP, FOMA, DABOM (CME credit available)

TO RECEIVE CONTINUING MEDICAL EDUCATION (CME) CREDIT CLICK LINK BELOW Access to CMEs for this activity expires ...

What does the FDA approval of MRD testing for myeloma mean for patients and drug development?

What does the FDA approval of MRD testing for myeloma mean for patients and drug development?

In this week's #AskDrDurie, myeloma expert Dr. Brian G.M. Durie answers the question: What